Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1716 ARTÍCULOS , VIENDO DEL 676 AL 690

The promise of microRNA-based therapies in Alzheimer's disease: challenges and perspectives

Walgrave H, Zhou L, De Strooper B, Salta E.

Mol Neurodegener. 2021 Nov 6;16(1):76. doi: 10.1186/s13024-021-00496-7.

Does Certainty of Genuine Treatment Increase the Drug Response in Alzheimer's Disease Patients: A Meta-Analysis and Critical Discussion

Matthiesen ST, Rosenkjær S, Pontén M, Jensen KB, Gottrup H, Vase L.

J Alzheimers Dis. 2021;84(4):1821-1832. doi: 10.3233/JAD-210108.

ApoE ε4 and IL-6-174G/C Polymorphism may Lead to Early Onset of Alzheimer's Disease with Atypical Presentation

Chakraborty S, Joardar A, Roy S, Gangopadhyay G, Biswas A.

Neurol India. 2021 Sep-Oct;69(5):1228-1233. doi: 10.4103/0028-3886.329604.

Emphasizing roles of BDNF promoters and inducers in Alzheimer's disease for improving impaired cognition and memory

Banerjee M, Shenoy RR.

J Basic Clin Physiol Pharmacol. 2021 Nov 8;34(2):125-136. doi: 10.1515/jbcpp-2021-0182. eCollection 2023 Mar 1.

The role of pathological tau in synaptic dysfunction in Alzheimer's diseases

Wu M, Zhang M, Yin X, Chen K, Hu Z, Zhou Q, Cao X, Chen Z, Liu D.

Transl Neurodegener. 2021 Nov 10;10(1):45. doi: 10.1186/s40035-021-00270-1.

An evidence-based review of neuronal cholesterol role in dementia and statins as a pharmacotherapy in reducing risk of dementia

Dutta S, Rahman S, Ahmad R, Kumar T, Dutta G, Banerjee S, Abubakar AR, Rowaiye AB, Dhingra S, Ravichandiran V, Kumar S, Sharma P, Haque M, Charan J.

Expert Rev Neurother. 2021 Dec;21(12):1455-1472. doi: 10.1080/14737175.2021.2003705. Epub 2021 Nov 29.

[Abdominal acupoint thread embedding therapy based on "brain-intestinal connection" for mild-to-moderate Alzheimer's disease and its effects on serum levels of APP and Aβ(1-42)]

Yang SQ, Fan DH, Yuan ZX, Su MY, Zhang ZN, Lin Y, Lin HG.

Zhongguo Zhen Jiu. 2021 Nov 12;41(11):1231-5. doi: 10.13703/j.0255-2930.20201106-k0002.

Block copolymers in Alzheimer's disease therapy: A perceptive to revolutionize biomaterials

Revdekar A, Shende P.

J Control Release. 2021 Dec 10;340:271-281. doi: 10.1016/j.jconrel.2021.11.007. Epub 2021 Nov 8.

Genome-wide analysis of common and rare variants via multiple knockoffs at biobank scale, with an application to Alzheimer disease genetics

He Z, Le Guen Y, Liu L, Lee J, Ma S, Yang AC, Liu X, Rutledge J, Losada PM, Song B, Belloy ME, Butler RR 3rd, Longo FM, Tang H, Mormino EC, Wyss-Coray T, Greicius MD, Ionita-Laza I.

Am J Hum Genet. 2021 Dec 2;108(12):2336-2353. doi: 10.1016/j.ajhg.2021.10.009. Epub 2021 Nov 11.

Pursuit of precision medicine: Systems biology approaches in Alzheimer's disease mouse models

Gurdon B, Kaczorowski C.

Neurobiol Dis. 2021 Dec;161:105558. doi: 10.1016/j.nbd.2021.105558. Epub 2021 Nov 10.

Disentangling Mitochondria in Alzheimer's Disease

Johri A.

Int J Mol Sci. 2021 Oct 26;22(21):11520. doi: 10.3390/ijms222111520.

Glutamate and GABA in Microglia-Neuron Cross-Talk in Alzheimer's Disease

Czapski GA, Strosznajder JB.

Int J Mol Sci. 2021 Oct 28;22(21):11677. doi: 10.3390/ijms222111677.

Alzheimer's Disease and Diabetes Mellitus in Comparison: The Therapeutic Efficacy of the Vanadium Compound

He Z, You G, Liu Q, Li N.

Int J Mol Sci. 2021 Nov 3;22(21):11931. doi: 10.3390/ijms222111931.

Evidence and Therapeutic Perspectives in the Relationship between the Oral Microbiome and Alzheimer's Disease: A Systematic Review

Maitre Y, Mahalli R, Micheneau P, Delpierre A, Amador G, Denis F.

Int J Environ Res Public Health. 2021 Oct 24;18(21):11157. doi: 10.3390/ijerph182111157.

Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer's Disease

Friedli MJ, Inestrosa NC.

Molecules. 2021 Oct 29;26(21):6531. doi: 10.3390/molecules26216531.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias